A novel kind of tumor type-characteristic junction: Plakophilin-2 as a major protein of adherens junctions in cardiac myxomata

Modern Pathology

Volumn 23, Issue 11, 2010, Pages 1429-1437

  Rickelt, Steffen ^a   Rizzo, Stefania ^b   Doerflinger, Yvette ^a,c   Zentgraf, Hanswalter ^a   Basso, Cristina ^b   Gerosa, Gino ^b   Thiene, Gaetano ^b   Moll, Roland ^d   Franke, Werner W ^a,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e Progen Biotechnik   (Germany)

Author keywords

adherens junctions; differential histodiagnosis; myxoma; plakophilin 2; puncta adhaerentia

Indexed keywords

ALPHA CATENIN; ARMADILLO DOMAIN PROTEIN; BETA CATENIN; BIOLOGICAL MARKER; CADHERIN; CADHERIN 11; CELL PROTEIN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; PLAKOPHILIN 2; PROTEIN ARVCF; PROTEIN P0071; PROTEIN P120; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CARDIAC MYXOMATA; CELL JUNCTION; CONTROLLED STUDY; DESMOSOME; DIAGNOSTIC VALUE; ELECTRON MICROSCOPY; HEART MYXOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALIGNANT TRANSFORMATION; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN TARGETING; SOFT TISSUE TUMOR;

ADHERENS JUNCTIONS; ALPHA CATENIN; ANTIGENS, CD; ARMADILLO DOMAIN PROTEINS; BETA CATENIN; CADHERINS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DESMOPLAKINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEART NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; MYXOMA; PHOSPHOPROTEINS; PLAKOPHILINS; TUMOR MARKERS, BIOLOGICAL;

EID: 78049453933     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.138     Document Type: Article

References (63)

1. Franke WW, Schmid E, Weber K, et al. HeLa cells contain intermediate-sized filaments of the prekeratin type. Exp Cell Res 1979;118:95-109.
2. Franke WW, Schmid E, Grund C, et al. Antibodies to high molecular weight polypeptides of desmosomes: specific localization of a class of junctional proteins in cells and tissue. Differentiation 1981;20:217-241.
3. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31: 11-24.
4. Franke WW, Moll R, Mueller H, et al. Immunocyto-chemical identification of epithelium-derived human tumors with antibodies to desmosomal plaque proteins. Proc Natl Acad Sci USA 1983;80:543-547.
5. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40: 403-439.
6. Miettinen M. Diagnostic Soft Tissue Pathology 1st edn. Churchill Livingstone: New York, Edinburgh, London, Philadelphia, 2003, pp 1-593.
7. Folpe AL, Gown A. Immunohistochemistry for analysis of soft tissue tumors In: Weiss S, Goldblum J (eds). Enzinger and Weiss's Soft Tissue Tumors Vol. 4. St Louis: Mosby, 2001, pp 199-245.
8. Ghadially FN. Diagnostic Electron Microscopy of Tumors. Butterworths: London, Boston, 1980, pp 1-251.
9. Erlandson RA. Diagnostic Transmission Electron Microscopy of Human Tumors. Masson Publishing USA: New York, Paris, Barcelona, 1981, pp 1-193.
10. Barth M, Schumacher H, Kuhn C, et al. Cordial connections: molecular ensembles and structures of adhering junctions connecting interstitial cells of cardiac valves in situ and in cell culture. Cell Tissue Res 2009 337 63-77.
11. Rickelt S, Winter-Simanowski S, Noffz E, et al. Upregulation of plakophilin-2 and its acquisition to adherens junctions identifies a novel molecular ensemble of cell-cell-attachment characteristic for transformed mesenchymal cells. Int J Cancer 2009;125: 2036-2048.
12. Mertens C, Kuhn C, Franke WW. Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque. J Cell Biol 1996;135:1009-1025.
13. Holmdahl R, Andersson M, Jansson L. A method for the analysis of a large number of specific and multi-specific B cell hybridomas derived from primary immunized lymph nodes. Hybridoma 1987;6:197-204.
14. Wuchter P, Boda-Heggemann J, Straub BK, et al. Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mese-nchymal stem cells. Cell Tissue Res 2007;328:499-514.
15. Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol) 2007;19:748-756.
16. Pieperhoff S, Franke WW. The area composita of adhering junctions connecting heart muscle cells of vertebrates. VI. Different precursor structures in non-mammalian species. Eur J Cell Biol 2008;87:413-430.
17. Franke WW, Borrmann CM, Grund C, et al. The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immuno-electron microscopy of desmosomal proteins. Eur J Cell Biol 2006;85:69-82.
18. Grossmann KS, Grund C, Huelsken J, et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol 2004;167: 149-160.
19. Stout AP. Myxoma, the tumor of primitive mesench-yme. Ann Surg 1948;127:706-719.
20. Amano J, Kono T, Wada Y, et al. Cardiac myxoma: its origin and tumor characteristics. Ann Thorac Cardio-vasc Surg 2003;9:215-221.
21. Jacot-Des-Combes E, Beyeler Y. Cardiac myxoma. Ultrastructural and immunohistochemical study of two cases. Ann Pathol 1982;2:223-228.
22. Takagi M. Ultrastructural and immunohistochemical characteristics of cardiac myxoma. Acta Pathol Jpn 1984;34:1099-1114.
23. Schuger L, Ron N, Rosenmann E. Cardiac myxoma. A retrospective immunohistochemical study. Pathol Res Pract 1987;182:63-66.
24. Johansson L. Histogenesis of cardiac myxomas. An immunohistochemical study of 19 cases, including one with glandular structures, and review of the literature. Arch Pathol Lab Med 1989;113:735-741.
25. Basso C, Valente M, Poletti A, et al. Surgical pathology of primary cardiac and pericardial tumors. Eur J Cardiothorac Surg 1997;12:730-738.
26. Loire R, Tabib A. Histopathologic study of cardiac myxoma. Apropos of 80 surgical cases. Arch Anat Cytol Pathol 1991;39:5-13.
27. Govoni E, Severi B, Cenacchi G, et al. Ultrastructural and immunohistochemical contribution to the histo-genesis of human cardiac myxoma. Ultrastruct Pathol 1988;12:221-233.
28. Orlandi A, Ciucci A, Ferlosio A, et al. Cardiac myxoma cells exhibit embryonic endocardial stem cell features. J Pathol 2006;209:231-239.
29. Curschellas E, Toia D, Borner M, et al. Cardiac myxomas: immunohistochemical study of benign and malignant variants. Virchows Arch A Pathol Anat Histopathol 1991;418:485-491.
30. Pucci A, Bartoloni G, Tessitore E, et al. Cytokeratin profile and neuroendocrine cells in the glandular component of cardiac myxoma. Virchows Arch 2003;443:618-624.
31. Ferrans VJ, Roberts WC. Structural features of cardiac myxomas. Histology, histochemistry, and electron microscopy. Hum Pathol 1973;4:111-146.
32. Valente M. Structural profile of cardiac myxoma. Appl Pathol 1983;1:251-263.
33. Stovin PG, Heath D, Khaliq SU. Ultrastructure of the cardiac myxoma and the papillary tumour of heart valves. Thorax 1973;28:273-285.
34. Kodama H, Hirotani T, Suzuki Y, et al. Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors. Am J Pathol 2002;161: 381-389.
35. Franke WW, Rickelt S, Barth M, et al. The junctions that don't fit the scheme: special symmetrical cell-cell junctions of their own kind. Cell Tissue Res 2009;338:1-17.
36. Franke WW. Discovering the molecular components of intercellular junctions\-a historical view In: Nelson J, Fuchs E (eds). Cold Spring Harbor Perspectives in Biology Vol. 1. Cold Spring Harbor Laboratory Press: New York, 2010, pp 1-34.
37. Strumane K, Berx G, Roy FV. Cadherins in cancer In: Behrens J, Nelson WJ (eds). Cell Adhesion Vol. 165. Springer Verlag: Berlin, Heidelberg, New York, 2004, pp 69-103.
38. Butany J, Nair V, Naseemuddin A, et al. Cardiac tumours: diagnosis and management. Lancet Oncol 2005;6:219-228.
39. Reynen K. Cardiac myxomas. N Engl J Med 1995;333:1610-1617.
40. Pucci A, Gagliardotto P, Zanini C, et al. Histopatholo-gic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 2000;140:134-138.
41. Burke AP, Heman T, Gomez-Roman JJ, et al. Tumours of the heart. Benign tumors of pluripotent mesench-yme. Cardiac myxoma In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press: Lyon, 2004, pp 260-263.
42. Orlandi A, Ciucci A, Ferlosio A, et al. Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas. Am J Pathol 2005;166:1619-1628.
43. Bass-Zubek AE, Godsel LM, Delmar M, et al. Plakophilins: multifunctional scaffolds for adhesion and signaling. Curr Opin Cell Biol 2009;21:708-716.
44. Borrmann CM, Grund C, Kuhn C, et al. The area composita of adhering junctions connecting heart muscle cells of vertebrates. II. Colocalizations of desmosomal and fascia adhaerens molecules in the intercalated disk. Eur J Cell Biol 2006;85:469-485.
45. Goossens S, Janssens B, Bonne S, et al. A unique and specific interaction between alphaT-catenin and plakophilin-2 in the area composita, the mixed-type junctional structure of cardiac intercalated discs. J Cell Sci 2007;120:2126-2136.
46. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-1164.
47. Van Tintelen JP, Entius MM, Bhuiyan ZA, et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation 2006;113:1650-1658.
48. Hall C, Li S, Li H, et al. Arrhythmogenic right ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome assembly and stability. Cell Com-mun Adhes 2009;16:15-27.
49. Oxford EM, Musa H, Maass K, et al. Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ Res 2007;101: 703-711.
50. Sato PY, Musa H, Coombs W, et al. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myo-cytes. Circ Res 2009;105:523-526.
51. Joshi-Mukherjee R, Coombs W, Musa H, et al. Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations. Heart Rhythm 2008;5:1715-1723.
52. Pieperhoff S, Schumacher H, Franke WW. The area composita of adhering junctions connecting heart muscle cells of vertebrates. V. The importance of plakophilin-2 demonstrated by small interference RNA-mediated knockdown in cultured rat cardiomyo-cytes. Eur J Cell Biol 2008;87:399-411.
53. Marcus FI, Nava A, Thiene G. Arrhytmogenic RV Cardiomyopathy/Dysplasia Recent Advances. Springer Verlag: Milan, 2007, pp 217.
54. Sakamoto H, Sakamaki T, Kanda T, et al. Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J 2004a;68:488-493.
55. Sakamoto H, Sakamaki T, Sumino H, et al. Production of endothelin-1 and big endothelin-1 by human cardiac myxoma cells-implications of the origin of myxomas. Circ J 2004b;68:1230-1232.
56. Gaumann A, Strubel G, Bode-Lesniewska B, et al. The role of tumor vascularisation in benign and malignant cardiovascular neoplasms: a comparison of cardiac myxoma and sarcomas of the pulmonary artery. Oncol Rep 2008;20:309-318.
57. Krikler DM, Rode J, Davies MJ, et al. Atrial myxoma: a tumour in search of its origins. Br Heart J 1992;67: 89-91.
58. Terracciano LM, Mhawech P, Suess K, et al. Calretinin as a marker for cardiac myxoma. Diagnostic and histo-genetic considerations. Am J Clin Pathol 2000;114: 754-759.
59. Suvarna SK, Royds JA. The nature of the cardiac myxoma. Int J Cardiol 1996;57:211-216.
60. Keeling IM, Oberwalder P, Anelli-Monti M, et al. Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg 2002;22:971-977.
61. Silverman NA. Primary cardiac tumors. Ann Surg 1980;191:127-138.
62. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors Vol. 4. St Louis: Mosby, 2001, pp 1-1622.
63. Blaschuk OW, Devemy E. Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol 2009;625: 195-198.